A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations

NCT07345689 PHASE4 NOT_YET_RECRUITING

The objective of this study is to evaluate the pharmacokinetic profile and safety of anaprazole sodium in adult subjects, particularly including the elderly and those with renal or hepatic impairment.

Details

Lead sponsor	Xuanzhu Biopharmaceutical Co., Ltd.
Phase	PHASE4
Status	NOT_YET_RECRUITING
Enrolment	60
Start date	Fri Jan 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jun 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Hepatic Insufficiency
• Renal Insufficiency
• Elderly

Interventions

• Anaprazole Sodium enteric-coated tablet

Countries

China